West Lafayette, IN, United States of America

Ramesh Mukkamala

This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Purdue Research Foundation, Ferronova Pty Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramesh Mukkamala. Retrieved from https://idiyas.com/inventor/ramesh-mukkamala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ramesh Mukkamala: Innovator in Nanoparticle Research

Introduction: Ramesh Mukkamala is an accomplished inventor based in West Lafayette, IN (US). He has made significant contributions to the field of nanoparticle research. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical applications.

Latest Patent Applications: Ramesh Mukkamala's latest patent applications include "Mapping Nanoparticles," which describes a nanoparticulate material suitable for administration to a subject. This material features a copolymeric steric stabilizer that promotes dispersion in a liquid and a copolymeric mapping moiety that targets fibroblast activation protein (FAP). Another application is "Compounds Targeting Fibroblast-Activation Protein and Methods of Use Thereof," which focuses on FAP-targeting compounds and methods for imaging cancer and fibrosis, as well as treating these conditions.

Conclusion: Ramesh Mukkamala's innovative work in nanoparticle research holds promise for future advancements in medical treatments. His contributions to the field are significant, and his ongoing research may lead to important breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…